Surrey and Sussex Cancer Alliance Promotes HPV Vaccination Uptake

The Surrey and Sussex Cancer Alliance is launching a campaign to encourage more young individuals in Sussex and Surrey to receive their Human papillomavirus (HPV) vaccinations. This initiative is part of a broader goal to eliminate specific cancer types associated with HPV by the year 2040.

HPV has been identified as a contributor to various cancers, particularly cervical cancer. Currently, approximately two-thirds of eligible children in these regions have received the vaccine, though uptake has not yet returned to the pre-Covid-19 pandemic levels.

The campaign specifically targets individuals aged 18 to 25, aiming to immunise those who missed vaccination opportunities during their schooling. Dr Alex Norman, the co-medical director of the cancer alliance, emphasised the significance of the HPV vaccine, stating, "The HPV vaccine is one of the most effective cancer prevention interventions available through the NHS."

He added, "We know some young people missed opportunities to be vaccinated during their school years, including during the pandemic," highlighting the need for renewed efforts to improve vaccination rates.

In past campaigns, particularly last year, there was a notable increase in vaccination rates within university communities, prompting a desire to build on this momentum.

HPV encompasses over 100 different virus types, with many affecting individuals without causing health problems. However, more severe strains can lead to cancers of the cervix as well as mouth and throat cancers. These viruses are typically transmitted through skin-to-skin or sexual contact.

The vaccine rollout began in England in 2008 for school-age girls, followed by the inclusion of boys in 2019. Research from earlier this year indicates that children vaccinated at ages 12 to 13 face almost no risk of dying from cervical cancer before turning 30.

Data from the cancer alliance revealed that by 2025, vaccination rates at General Practitioner clinics that cater to universities had surged by 117% compared to the previous year. Young adults interested in obtaining the vaccine can contact their GP practice for further assistance.

To support the campaign, promotional materials such as posters and flyers were distributed at four universities in Sussex and Surrey.

Dr Amy Dissanayake, deputy chief medical officer at NHS Surrey and Sussex, remarked: "Every vaccination represents an opportunity to prevent cancer before it develops." She expressed satisfaction with the collaboration among various partners to enhance awareness regarding HPV vaccine eligibility and its benefits.

In addition, the NHS is reaching out to women in Lincolnshire as part of the cervical screening programme, informing them that even those who have had the HPV vaccine should continue to participate in regular screenings. Eligible women may order free self-testing kits online via the NHS app.

Concerns have also been raised regarding the accessibility of smear tests for autistic women, with reports of distress and feelings of dismissal leading some to avoid these essential health checks altogether.